Haemonetics Corporation Reports 4th Quarter Fiscal 2014 Revenue Of $241 Million And Adjusted EPS Of $0.46; Full Year Revenue Of $939 Million, Up 5% And Adjusted EPS Of $2.19, Up 10%

BRAINTREE, Mass., April 28, 2014 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported revenue for the fourth quarter fiscal 2014 of $241.1 million, down 4%. Excluding currency impact, revenue was down 2% in the quarter.(1) The Company’s base revenue, exclusive of the recently acquired whole blood business, increased 2% on a constant currency basis in the quarter.

Help employers find you! Check out all the jobs and post your resume.